The concept of pharmacologic cocaine interception as a treatment for drug abuse

Chemico-Biological Interactions

Volumn 187, Issue 1-3, 2010, Pages 421-424

  Gao, Yang ^a   Orson, Frank M ^b   Kinsey, Berma ^b   Kosten, Tom ^c   Brimijoin, Stephen ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Anti cocaine antibody; Butyrylcholinesterase; Cocaine hydrolase; Cocaine vaccine

Indexed keywords

COCAINE; COCAINE ANTIBODY; COCAINE HYDROLASE; HYDROLASE; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; COCAINE DEPENDENCE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG BINDING; DRUG BRAIN LEVEL; DRUG DEPENDENCE TREATMENT; DRUG HYDROLYSIS; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME THERAPY; MOUSE; NEUROPROTECTION; NONHUMAN; THEORETICAL STUDY;

MUS; RATTUS; RODENTIA;

EID: 77954566230     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.02.036     Document Type: Article

References (32)

1. Pan Y., Gao D., Yang W., Cho H., Yang G., Tai H.H., Zhan C.G. Computational redesign of human butyrylcholinesterase for anticocaine medication. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:16656-16661.
2. Sun H., Pang Y.-P., Lockridge O., Brimijoin S. Re-engineering butyrylcholinesterase as a cocaine hydrolase. Mol. Pharmacol. 2002, 621:220-224.
3. Zheng F., Yang W., Ko M.C., Liu J., Cho H., Gao D., Tong M., Tai H.H., Woods J.H., Zhan C.G. Most efficient cocaine hydrolase designed by virtual screening of transition states. J. Am. Chem. Soc. 2008, 130:12148-12155.
4. Landry D.W. Immunotherapy for cocaine addiction. Sci. Am. 1997, 276:42-45.
5. Orson F.M., Kinsey B.M., Singh R.A., Wu Y., Gardner T., Kosten T.R. Substance abuse vaccines. Ann. N. Y. Acad. Sci. 2008, 1141:257-269.
6. Orson F.M., Kinsey B.M., Singh R.A., Wu Y., Kosten T.R. Vaccines for cocaine abuse. Hum. Vaccines 2009, 5.
7. Misra A.L., Giri V.V., Patel M.N., Alluri V.R., Mule S.J. Disposition and metabolism of [3H] cocaine in acutely and chronically treated monkeys. Drug Alcohol Depend. 1977, 2:261-272.
8. Saxena A., Sun W., Luo C., Myers T.M., Koplovitz I., Lenz D.E., Doctor B.P. Bioscavenger for protection from toxicity of organophosphorus compounds. J. Mol. Neurosci. 2006, 30:145-148.
9. Gao Y., Brimijoin S. An engineered cocaine hydrolase blunts and reverses cardiovascular responses to cocaine in rats. J. Pharmacol. Exp. Ther. 2004, 310:1046-1052.
10. Sun H., Shen M., Pang Y.-P., Lockridge O., Brimijoin S. Cocaine metabolism accelerated by a re-engineered human butyrylcholinesterase. J. Pharmacol. Exp. Ther. 2002, 302:710-716.
11. Pancook J.D., Pecht G., Ader M., Lockridge M.M.O., Watkins J.D. Application of directed evolution technology to optimize the cocaine hydrolase activity of human butyrylcholineserase. FASEB J. 2003, 17:A565.
12. Staros J.V., Wright R.W., Swingle D.M. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal. Biochem. 1986, 156:220-222.
13. Steward M.W. Introduction to methods used to study the affinity and kinetics of antibody-antigen reactions. Handbook of Experimental Immunology, vol. 1 1986, 25.21-25.30. Blackwell Scientific, Oxford. D.M. Weir (Ed.).
14. Gao Y., LaFleur D., Shah R., Zhao Q., Singh M., Brimijoin S. An albumin-butyrylcholinesterase for cocaine toxicity and addiction: catalytic and pharmacokinetic properties. Chem. Biol. Interact. 2008, 175:83-87.
15. Brimijoin S., Shen M., Sun H. Radiometric solvent-partitioning assay for screening cocaine hydrolases and measuring cocaine levels in milligram tissue samples. Anal. Biochem. 2002, 309:200-205.
16. Stewart D.J., Inaba T., Tang B.K., Kalow W. Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci. 1977, 20:1557-1564.
17. Lynch T., Mattes C., Singh A., Bradley R., Brady R., Dretchen K. Cocaine detoxification by human plasma butyrylcholinesterase. J Appl. Pharmacol. 1997, 145:363-371.
18. Brimijoin S., Gao Y., Anker J.J., Gliddon L.A., Lafleur D., Shah R., Zhao Q., Singh M., Carroll M.E. A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats. Neuropsychopharmacology 2008, 33:2715-2725.
19. Gao Y., Brimijoin S. Lasting reduction of cocaine action in neostriatum-a hydrolase gene therapy approach. J Pharmacol Exp Ther 2009, 330:449-457.
20. Kosten T., Owens S.M. Immunotherapy for the treatment of drug abuse. Pharmacol. Ther. 2005, 108:76-85.
21. Fox B.S. Development of a therapeutic vaccine for the treatment of cocaine addiction. Drug Alcohol Depend. 1997, 48:153-158.
22. Stitzer M.L., Polk T., Bowles S., Kosten T. Drug users' adherence to a 6-month vaccination protocol: effects of motivational incentives. Drug Alcohol Depend. 2009.
23. Martell B.A., Orson F.M., Poling J., Mitchell E., Rossen R.D., Gardner T., Kosten T.R. Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Arch. Gen. Psychiatry 2009, 66:1116-1123.
24. Jufer R.A, Walsh S.L., Cone E.J. Cocaine and metabolite concentrations in plasma during repeated oral administration: development of a human laboratory model of chronic cocaine use. J. Anal. Toxicol. 1998, 22:435-444.
25. Walsh S.L., Stoops W.W., Moody D.E., Lin S.N., Bigelow G.E. Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics. Exp. Clin. Psychopharmacol. 2009, 17:205-216.
26. Fox B.S, Kantak K.M., Edwards M.A., Black K.M., Bollinger B.K., Botka A.J., French T.L., Thompson T.L., Schad V.C., Greenstein J.L., Gefter M.L., Exley M.A., Swain P.A., Briner T.J. Efficacy of a therapeutic cocaine vaccine in rodent models. Nat. Med. 1996, 2:1129-1132.
27. Carrera M.R., Ashley J.A., Zhou B., Wirsching P., Koob G.F., Janda K.D. Cocaine vaccines: antibody protection against relapse in a rat model. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6202-6206.
28. Gao Y., Atanasova E., Sui N., Pancook J.D., Watkins J.D., Brimijoin S. Gene transfer of cocaine hydrolase suppresses cardiovascular responses to cocaine in rats. Mol. Pharmacol. 2005, 67:204-211.
29. Cashman J.R. Biocatalysts in detoxication of drugs of abuse. NIDA Res. Monogr. 1997, 173:225-258.
30. Landry D.W., Zhao K., Yang G.X.-Q., Glickman M., Georgiadis T.M. Antibody-catalyzed degradation of cocaine. Science 1993, 259:1899-1901.
31. Mets B., Winger G., Cabrera C., Seo S., Jamdar S., Yang G., Zhao K., Briscoe R.J., Almonte R., Woods J.H., Landry D.W. A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:10176-10181.
32. McKenzie K.M., Mee J.M., Rogers C.J., Hixon M.S., Kaufmann G.F., Janda K.D. Identification and characterization of single chain anti-cocaine catalytic antibodies. J. Mol. Biol. 2007, 365:722-731.